Hsp90-mediated inhibition of FKBP38 regulates apoptosis in neuroblastoma cells |
| |
Authors: | Erdmann Frank Jarczowski Franziska Weiwad Matthias Fischer Gunter Edlich Frank |
| |
Affiliation: | Max-Planck Research Unit for Enzymology of Protein Folding, Weinbergweg 22, D-06120, Halle/Saale, Germany. |
| |
Abstract: | The FK506-binding protein 38 (FKBP38) is a pro-apoptotic regulator of Bcl-2 in neuroblastoma cells. Hsp90 inhibits the pro-apoptotic FKBP38/CaM/Ca(2+) complex and thus prevents interactions between FKBP38 and Bcl-2. Here we show that Hsp90 increases cell survival rates of neuroblastoma cells after apoptosis induction. Depletion of FKBP38 by short interference RNA significantly decreased the anti-apoptotic effect of Hsp90 expression. In addition, the influence of high cellular Hsp90 levels was only observed in post-stimulation apoptosis that is sensitive to selective FKBP38 active site inhibition. Similar anti-apoptotic effects in neuroblastoma cells were observed after stimulation of endogenous Hsp90 expression. Hence, the inhibition of FKBP38 by Hsp90 participates in programmed cell death control of neuroblastoma cells. |
| |
Keywords: | FKBP, FK506-binding protein PPIase, peptidyl-prolyl cis/trans isomerases siRNA, short interference RNA TPR, tetratricopeptide repeat IAA, iodoacetic acid |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|